Home/Filings/4/0000905718-17-000829
4//SEC Filing

Rongen Roelof 4

Accession 0000905718-17-000829

CIK 0001582554other

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 9:00 AM ET

Size

4.6 KB

Accession

0000905718-17-000829

Insider Transaction Report

Form 4
Period: 2017-09-08
Rongen Roelof
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2017-09-08$1.36/sh+5,000$6,8003,539,416 total

Issuer

Matinas BioPharma Holdings, Inc.

CIK 0001582554

Entity typeother

Related Parties

1
  • filerCIK 0001698966

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 9:00 AM ET
Size
4.6 KB